MEDDEV 2.12-2 医疗器械上市后临床跟踪指南.pdfVIP

EUROPEAN COMMISSION DG ENTERPRISE Directorate G Unit 4 - Pressure Equipment, Medical Devices, Metrology MEDICAL DEVICES: Guidance document MEDDEV 2.12-2 May 2004 GUIDELINES ON POST MARKET CLINICAL FOLLOW-UP 上市后临床跟踪指南 The present Guidelines are part of a set of Guidelines relating to questions of application of EC-Directives on medical devices. They are legally not binding. The Guidelines have been carefully drafted through a process of intensive consultation of the various interested parties (competent authorities, Commission services, industries, other interested parties) during which intermediate drafts were circulated and comments were taken up in the document. Therefore, this document reflects positions taken by representatives of interested parties in the medical devices sector. 本准则是一个有关的欧共体指令对医疗设备的应用问题指引的一部分。他们在法 律上没有约束力。该指引已审慎草拟通过各有关方面（主管机关，委员会的服务， 工业，其他有关各方）在此期间，中间草案分发和评论的文件采取了密集的磋商 进程。因此，这份文件反映了有关各方的代表在该领域采取的医疗设备的位置。 Foreword : Rationale and Goals of PMCF This document is intended to be a guide for manufacturers and notified bodies on how to carry out PMCF in order to fulfill post market surveillance obligation according to point 3. 1 of annex II, point 3. of annex IV, point 3 of annex V, point 3.1 of annex VI or point 4 of annex VII of medical device directive (add ref. AIMDD) While clinical evidence is an essential element of the premarket conformity assessment process, it is important to recognize the limitations inherent to these premarket clinical investigations. The extent of the data that can be gathered in the premarket phase does not enable the manufacturer to detect infrequent complications or problems only apparent after widespread use, or /long term performance issues. As part of the manufacturer’s quality system, a